You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (182)

Journals (0)

1-10 of 182 results for anti-PD-1 inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases

Retricted access

Case report

First published 2022-7

Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases

Zheng Yan, Shuna Yao, Junhui Yuan [...]

Journal of Oncology Pharmacy Practice

Select article: PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Open access

Research article

First published 2024-5

PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Sixu Zhou, Baogui Wang, Yingying Wei [...]

Cancer Biomarkers

Select article: Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis

Open access

Research article

First published 2025

Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis

Linjing Zhou, Yuwei Li, Le Wang [...]

Therapeutic Advances in Medical Oncology

Select article: Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer

Open access

Case report

First published 2020

Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer

Harry J. Han, Yun Rose Li, Mack Roach [...]

Therapeutic Advances in Medical Oncology

Select article: Nivolumab in melanoma: latest evidence and clinical potential

Free access

Review article

First published 2015-3

Nivolumab in melanoma: latest evidence and clinical potential

Douglas B. Johnson, Chengwei Peng, Jeffrey A. Sosman

Therapeutic Advances in Medical Oncology

Select article: Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Open access

Research article

First published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Clinical assessment of immune-related adverse events

Open access

Review article

First published 2018

Clinical assessment of immune-related adverse events

Aaron Sosa, Esther Lopez Cadena, Cristina Simon Olive [...]

Therapeutic Advances in Medical Oncology

Select article: Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience

Open access

Research article

First published 2023

Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience

Qingyan Liu, Rong Li, Lingling Li [...]

Therapeutic Advances in Medical Oncology

Select article: Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study

Retricted access

Article commentary

First published 2019-4

Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study

Sarbajit Mukherjee, Sami Ibrahimi, Bilal Khalid [...]

Journal of Oncology Pharmacy Practice

1
2
3
•••
19
10 / page

Article type

Publication date

Subjects

Access